The tetracyclines have a wide spectrum of usage in venereology and are used in the treatment of gonorrhoea, syphilis, lymphogranuloma venereum, granuloma inguinale, soft sore, and non-gonococcal urethritis. For the treatment of gonorrhoea and syphilis, from considerations of effectiveness, cost, and absence of a suitable injectable tetracycline preparation, penicillin has been preferred, but for more than 20 years the tetracyclines have been the first choice for the treatment of non-gonococcal urethritis. Chlortetracycline, prepared from Streptomyces aureofaciens, was the earliest tetracycline to be discovered by Duggar (1948) . It was soon used in the treatment of non-gonococcal urethritis in two cases by Finland, Collins, and Paine (1948) in the U.S.A. and in four cases in Great Britain by Willcox and Findlay (1949) . Other compounds, notably oxytetracycline and tetracycline itself, soon followed, and as their costs were reduced they gradually assumed precedence over the cheaper but less effective regimen involving an injection of streptomycin and oral sulphonamides which were then generally used in the venereal disease clinics of Great Britain.
Since the introduction of chlortetracycline there has been much laboratory research to evolve better tetracyclines, from the discovery of new antibiotics from other actinomycetes, from cultivating the mutant strains, or by the chemical modification of the natural products. Today a considerable array of tetracycline compounds are available. These include chlortetracycline, oxytetracycline, tetracycline, lymecycline, demethylchlortetracycline, clomocycine, methacycline, and doxycycine; all have been used in the treatment of non-gonococcal urethritis.
Minocycline
One of the latest to emerge is minocycline (7-dimethylamino-6-deoxy-6-demethyl tetracycline), which has the basic tetracycline structure but with the removal of the methyl and hydroxyl groups at position 6 and with a repetition of the dimethyl amino group of the 4-position at position 7 (Martell and against certain tetracycline-resistant bacteria, especially the staphylococcus. A number of workers, e.g. Thatcher, Pazin, and Domescik (1970), Pariser and Marino (1970) and Duncan, Glicksman, Knox, and Holder (1971) However, apart from that of Fowler (1974) , there are few, if any, reports of its action in non-gonococcal urethritis, which forms the subject of this paper.
As the earlier treatment regimens with oxytetracycline and other drugs which are used for comparison have usually been applied over six days this treatment has also been employed in the minocycline study. The patients were instructed to return after 1 week, when a urethral smear was again taken. It was planned that they be seen subsequently at 2 and then at approximately 6 and 12 weeks from treatment; at each of these visits the urethra was examined for discharge, a smear being taken if any were present, and the urine inspected for haze and threads. Re-treatment was undertaken if a pus-containing discharge was present, if significant pus was found in the smear in the absence of visible discharge, or if the urine was hazy or contained a number of persistent threads. Patients complaining of early morning discharge but without other signs were given a slide to collect material for examination. It was planned also to make at least one examination of the prostatic secretion during surveillance and to do final serum tests for syphilis at three months.
Follow-up and results
Not all of the patients attended at the times requested, but more than half were seen over periods of 3 weeks or more. Moreover, as approximately 85 per cent. of the patients were born in the United Kingdom and were treated in the sole clinic covering a wide area, it was felt that those who failed to respond to treatment would be more than usually likely to return to the same clinic. The follow-up and results obtained are shown in Table I .
Of the 108 patients treated, 96 were followed. The status was satisfactory at the last visit in eighty, three were treated for a fresh gonococcal infection, and ten (10-4 per cent. of those followed) were re-treated for a non-gonococcal infection within 3 post-treatment months.
No attempt has been made to separate relapse from re-infection. Gonorrhoea has a short incubation period, but that of non-gonococcal urethritis is very variable, perhaps from 2 days to 6 weeks, and an arbitary distinction of relapse from re-infection based on the time of recurrence, which is frequently used in the assessment of the results of treatment of There was nothing to suggest a higher failure rate in the small number of immigrants included in the series (Table II) . Results according to a previous history of non-specific urethritis In an earlier reported series of cases ofnon-gonococcal urethritis treated with cotrimoxazole (Willcox and Sparrow, 1974) , it was noted that a higher recurrence rate was encountered amongst those patients who had previously contracted non-gonococcal urethritis than those who had not. The findings in this respect in the minocycline series are shown in Table III. Comparison with tetracyclines under similar conditions In Table IV the results obtained are compared with those previously reported under similar conditions in the same clinic when oxytetracycline 250 mg. was given four times a day for 6 days.
Notwithstanding any considerations of cost, the treatment with minocycline not only appeared to give somewhat better results but had the added advantage that the medication was simpler, being required only twice instead of four times daily.
Comparison with other agents
The results obtained with minocycline are compared in Table V with those previously reported with other tetracyclines and antibiotics or chemotherapeutic drugs using the same assessment criteria (see Wilcox and Sparrow, 1974; Willcox, 1972) .
These convincingly indicate the superiority of the tetracyclines over other agents tested, and while it is difficult to separate with statistical significance a number of individual tetracyclines the best results combined with ease of administration were clearly provided by minocycline.
It is also of interest to observe that there are no signs of developing resistance of the causative agent of non-gonococcal urethritis to tetracyclines, for the results obtained in the more recent series using oxytetracycline were comparable to those observed in the same and another clinic 16 years earlier.
Results in cases ofgonorrhoea
The minocycline regimen outlined was also successful in the treatment of the seven cases of gonorrhoea which were excluded from the study. One of these patients defaulted immediately, the status at the last visit was satisfactory in four (at 7, 17, 70, and 98 days respectively), one was re-infected by his wife after 23 days, and another re-infected from a new source after 70 days. There were no known recurrences within 2 weeks.
Side-effects The drug in the dosage given was well tolerated. The only side-effect reported by the 102 patients followed of the 115 treated was of soreness of the mouth at 1 week in two cases. One of these patients consulted his general practitioner and was told that the lesions were due to thrush but no pathological confirmation was sought.
Summary and conclusions
108 male patients with non-gonococcal urethritis have been treated with minocycline given as two 100 mg. tablets initially, followed by one tablet twice a day over a period of 6 days (13 tablets). Of 96 patients followed, re-treatnent for non-gonococcal urethritis within 3 months was undertaken in ten (104 per cent.). The findings are compared with those previously reported in seven series involving six other tetracyclines and with nine other treatment regimens. All of the tetracyclines proved superior to other agents and the best results combined with simplicity of administration were obtained with minocycline.
Two patients complained of soreness of the mouth after 1 week but no other side-effects were reported.
Minocycline thus gives excellent results in the treatmnent of non-gonococcal urethritis. In the dosage used it was also successful against gonorrhoea in seven patients treated. It in cases in which gonorrhoea is suspected but not found in the smears or in which the smears cannot be read immediately.
